IMUX
IMUX
NASDAQ · Biotechnology

Immunic Inc

$14.80
-0.01 (-0.07%)
As of Jul 4, 2:20 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +66.8% upside
Low Target $14.59
Average Target $24.69
High Target $25.91
Current Price $14.80
Current
$14.80
Target
$24.69
$14.59 $24.69 avg $25.91
Scenario Analysis
Bear Case
$14.59
-1.4%
Low target
Base Case
$24.69
+66.8%
Avg target
Bull Case
$25.91
+75.1%
High target
Risk/Reward
52.9x
Highly favorable
Price in Context
52-Week High
$15.84
-6.6% from high
52-Week Low
$5.06
+192.5% from low
Target vs 52W High
$24.69
+55.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 -1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -49.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +176.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -88.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -67.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.8%